These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15538999)

  • 1. The metabolic syndrome and type 2 diabetes: what has gone wrong in type 2 diabetes care?
    Waldhäusl WK
    Curr Diab Rep; 2004 Dec; 4(6):395-6. PubMed ID: 15538999
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolic syndrome, resistance to insulin and diabetes. What is hidden beneath the tip of the iceberg?].
    Costa B; Cabré JJ; Martín F
    Aten Primaria; 2003 Apr; 31(7):436-45. PubMed ID: 12735887
    [No Abstract]   [Full Text] [Related]  

  • 3. The metabolic syndrome, inflammation and cardiovascular disease in type 2 diabetes.
    Roberts AW; Evans M
    Curr Opin Lipidol; 2004 Feb; 15(1):89-91. PubMed ID: 15166815
    [No Abstract]   [Full Text] [Related]  

  • 4. The coming of age of the metabolic syndrome.
    Alexander CM
    Diabetes Care; 2003 Nov; 26(11):3180-1. PubMed ID: 14578259
    [No Abstract]   [Full Text] [Related]  

  • 5. A case study approach, combined with modified team-based learning, to teach the progression of metabolic syndrome to type 2 diabetes.
    Gopalan C; Kist W
    Adv Physiol Educ; 2018 Mar; 42(1):84-89. PubMed ID: 29341805
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in features of the metabolic syndrome and incident impaired glucose regulation or type 2 diabetes in a chinese population.
    Wang JJ; Hu G; Lappalainen J; Miettinen ME; Qiao Q; Tuomilehto J
    Diabetes Care; 2005 Feb; 28(2):448-50. PubMed ID: 15677815
    [No Abstract]   [Full Text] [Related]  

  • 7. Exercise, fitness, and cardiovascular disease risk in type 2 diabetes and the metabolic syndrome.
    Duncan GE
    Curr Diab Rep; 2006 Feb; 6(1):29-35. PubMed ID: 16522278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and the cluster of abnormalities related to the metabolic syndrome are associated with reduced glomerular filtration rate in patients with type 2 diabetes.
    De Cosmo S; Trevisan R; Minenna A; Vedovato M; Viti R; Santini SA; Dodesini AR; Fioretto P; Trischitta V
    Diabetes Care; 2006 Feb; 29(2):432-4. PubMed ID: 16443904
    [No Abstract]   [Full Text] [Related]  

  • 9. The metabolic syndrome: the emperor needs some consistent clothes.
    Vinicor F; Bowman B
    Diabetes Care; 2004 May; 27(5):1243; author reply 1244. PubMed ID: 15111565
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to the editor.
    Oosterlinck W; Herijgers P
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1721. PubMed ID: 24793606
    [No Abstract]   [Full Text] [Related]  

  • 11. A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM) by the European NIDDM Policy Group.
    Sinclair AJ
    Diabet Med; 1995 Aug; 12(8):724. PubMed ID: 7587015
    [No Abstract]   [Full Text] [Related]  

  • 12. Should the gender and age of an animal be considered for studies on postconditioning?
    Son KH; Choi CH; Park CH; Jeon YB; Lee JI; Park KY
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1720. PubMed ID: 24793605
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistin: an inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome.
    Abate N; Sallam HS; Rizzo M; Nikolic D; Obradovic M; Bjelogrlic P; Isenovic ER
    Curr Pharm Des; 2014; 20(31):4961-9. PubMed ID: 24320036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and its evolving link to diabetes.
    Cooppan R
    Postgrad Med; 2005 Nov; 118(5):7-10, 14. PubMed ID: 16329526
    [No Abstract]   [Full Text] [Related]  

  • 15. Synergistic association of metabolic syndrome and overt nephropathy with elevated asymmetric dimethylarginine in serum and impaired cutaneous microvasodilation in patients with type 2 diabetes.
    Yamamoto R; Aso Y
    Diabetes Care; 2006 Apr; 29(4):928-30. PubMed ID: 16567841
    [No Abstract]   [Full Text] [Related]  

  • 16. Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes.
    Trost S; Pratley R; Sobel B
    Curr Diab Rep; 2006 Feb; 6(1):47-54. PubMed ID: 16522281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome.
    Summers SA; Nelson DH
    Diabetes; 2005 Mar; 54(3):591-602. PubMed ID: 15734832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes mellitus in adolescence: lipid and cardiovascular risk factors.
    Jones KL; Dewan AK
    Curr Diab Rep; 2003 Jun; 3(3):255-62. PubMed ID: 12762975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift.
    Nolan CJ; Prentki M
    Diab Vasc Dis Res; 2019 Mar; 16(2):118-127. PubMed ID: 30770030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the cardiometabolic syndrome.
    Sowers JR
    Clin Cornerstone; 2001; 4(2):17-23. PubMed ID: 11838324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.